The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Brennan Kevin M. since 2026.
This trader's CIK number is 1971303.
At the time of last reporting, Brennan Kevin M. was the SVP, FINANCE AND ACCOUNTING of Xilio Therapeutics, Inc.. (stock ticker symbol XLO).
Also see all insider trading activities at Xilio Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | XLO | 0 | $0 | 5,478 | $3,522 | 15,000 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-01-02 | XLO | Sale | 1,826 | .64 | 1,174 |
| 2026-01-01 | XLO | Option Ex | 5,000 | .00 | 0 |
| 2026-01-02 | XLO | Sale | 1,826 | .64 | 1,174 |
| 2026-01-01 | XLO | Option Ex | 5,000 | .00 | 0 |
| 2026-01-02 | XLO | Sale | 1,826 | .64 | 1,174 |
| 2026-01-01 | XLO | Option Ex | 5,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Brennan Kevin M. (SVP, FINANCE AND ACCOUNTING of Xilio Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.